Rhythm Biosciences Ltd (ASX: RHY) Acquires Genetype Business
Rhythm Biosciences (ASX: RHY) has acquired Genetype assets, enhancing its oncology portfolio and positioning for immediate revenue growth.
Tag: Dividends & Share Buybacks
Euroz Hartleys Group Limited (ASX:EZL) Announces Buy-Back Extension
Euroz Hartleys Group Limited announces the extension of its on-market buy-back programme for an additional year, now running through early 2026.
FBR Limited (ASX:FBR) Completes US Demonstration Program
FBR Limited successfully completes its US Demonstration Program, paving the way for an exclusive joint venture for construction robots.
Mach7 Technologies Limited (ASX:M7T) Signs New Contracts Worth A$4.6M
Mach7 Technologies Limited (ASX:M7T) announces the signing of A$4.6M in new contracts to enhance its PACS solutions and future revenue growth.
Elanor Investors Group (ASX: ENN) Market Update and FY24 Forecast
Elanor Investors Group updates the market on its financial situation and forecasts for FY24 after refinancing efforts.
IGO Limited (ASX:IGO) Provides Lithium Business Update
IGO Limited updates on Kwinana Lithium Hydroxide Refinery amid market conditions impacting dividends.
Acrux Limited (ASX:ACR) Raises $1.34 Million from Share Purchase Plan
Acrux Limited (ASX:ACR) raises $1.34 million through its Share Purchase Plan to advance its pharmaceutical development pipeline.
Pengana Private Equity Trust (ASX:PE1) Announces Dividend Distribution
Pengana Private Equity Trust announces a dividend distribution of AUD 0.03176 per unit, payable on January 29, 2025.
Eildon Capital Group (ASX:EDC) Announces Half Year Dividend
Eildon Capital Group (ASX:EDC) announces a fully franked dividend of 4.0 cents per stapled security for the half year ending December 2024.
EILDON CAPITAL GROUP (ASX:EDC) Announces Dividend Distribution
Eildon Capital Group (ASX:EDC) announces an AUD 0.04 dividend distribution, with payment scheduled for January 22, 2025.